Search
Menu
Home
HTB
2001
June
HTB
June 2001
Contents
Conference reports
4th International Conference on Nutrition and HIV Infection and the 2nd European Workshop on Lipodystrophy, April 19-21, 2001, Cannes, France
4th International Conference on Nutrition and HIV Infection and the 2nd European Workshop on Lipodystrophy – pt 2
Keystone Symposium on HIV, March 28-April 3, Keystone, Colorado: more than one way to skin a virus: innate immune factors that suppress HIV replication
Antiretrovirals
Tenofovir: Gilead applies for approval, expanded access relaxed
Treatment access
Cipla announces plan to manufacture 3-in-1 HIV pil
Huge mining firm to provide African employees with AIDS medications
South African Department of health has not killed possibility of AIDS drug provision, letter says
Government, pricing not the only problems
South Africa AIDS drug settlement may not signify immediate influx of drugs
AIDS crisis has Sspurred public relations challenges for pharmaceutical industry, Wall Street Journal reports
Women's health
A new women’s research agenda starts to see the light of day
Incidence of invasive cervical cancer in a cohort of HIV-infected women before and after the introduction of HAART
Paediatric care
Protease inhibitor therapy improves growth parameters of HIV-infected children
Coinfections and complications
CD4+ counts predictive of musculoskeletal manifestations of HIV infection
Effect of highly active antiretroviral therapy on frequency of oral warts
Drug resistance
HIV drug resistance is increasing in the UK
Other news
The relationships between ethnicity, sex, risk group,and virus load in HIV-1 antiretroviral-naive patients
FDA warning to manufacturers of antiretrovirals over misleading advertising
Mbeki questions validity of HIV testing
Aerobic exercise benefits HIV-positive adults
Whey proteins help replenish glutathione levels
Therapeutic drug monitoring: ready For clinical practice?
Expert column: recent developments and current issues in HIV-related renal disease
HPV-induced anal dysplasia: what do We know and what can we do about it?
PDFs
Volume 2 Number 5 June 2001 PDF
HTB RSS
Early access
HIV guidelines recommend a statin for all people older than 40: new BHIVA document
21 November 2023
Dolutegravir monotherapy still not recommended: 4-year follow up in early-treated durably suppressed participants
12 November 2023
CHAI 2023 market report: decline in HIV funding threatens 20 years of progress
2 November 2023
Mpox vaccines still available and recommended in the UK and US
2 November 2023
All early access reports
Current issues
November 2023
October 2023
September 2023
Back issues
Special report
Uganda report: Increase in LGBTQI+ assaults and human rights violations need urgent activist responses
1 October 2023
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage